Premier Partners provides managed laboratory solutions to streamline and advance drug development programs for emerging biopharma companies. Contact us to learn how Premier Partners can optimize your nonclinical & early clinical programs.
Serving as an integrated extension of your team, Premier Partners helps you reach critical decisions faster. We provide study design, nonclinical laboratory selection, and program management solutions to drive a seamless transition into the clinic – and beyond. Our collaborative, proactive approach manages risk and keeps your timeline on track.
Key benefits:
This white paper offers insight into nonclinical study requirements and recommendations for putting together an optimal nonclinical team.
This guide explains why successful nonclinical strategies leverage smart design and planning to minimize risk in critical early-stage milestones.
In this webinar, our experts discuss how to prepare for conducting and managing IND-enabling nonclinical studies while meeting FDA guidelines.
Our experienced team of drug development experts is committed to helping you reach critical decisions faster. With your research goals in mind, we provide study design, nonclinical laboratory selection, and program management solutions to execute a full range of GLP and non-GLP preclinical evaluation studies and advance your program to first-in-human studies.
Transition into the clinic and set your sights on moving to and through proof of concept with CMC and early clinical support.
Our team brings diverse scientific and drug development expertise in areas including ADME/PK, bioanalysis, CMC, pharmacology, toxicology, and early clinical development. We leverage Premier Consulting’s Quality Management support capabilities to stay at the forefront of quality and compliance standards. We can support both non-regulated exploratory studies as well as regulated studies following GLP, GMP or GCP. The compounds and studies we support include:
